Woodmark Pharmacy Revenue and Competitors

Buffalo, NY USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Woodmark Pharmacy's estimated annual revenue is currently $25.4M per year.(i)
  • Woodmark Pharmacy's estimated revenue per employee is $325,385

Employee Data

  • Woodmark Pharmacy has 78 Employees.(i)
  • Woodmark Pharmacy grew their employee count by 7% last year.

Woodmark Pharmacy's People

NameTitleEmail/Phone
1
Director Clinical Pharmacy Services & EducationReveal Email/Phone
2
Manager RecordReveal Email/Phone
3
Billing Office ManagerReveal Email/Phone
4
Clinical PharmacistReveal Email/Phone
5
Certified Pharmacy TechnicianReveal Email/Phone
6
Pharmacy Billing SpecialistReveal Email/Phone
7
Consultant PharmacistReveal Email/Phone
8
PharmacistReveal Email/Phone
9
Staff PharmacistReveal Email/Phone
10
PharmacistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M23-8%N/AN/A
#2
$13.4M4914%N/AN/A
#3
$25.4M787%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$9.3M330%N/AN/A
#6
$51.1M14811%N/AN/A
#7
$65M1700%N/AN/A
#8
$44.8M1519%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$9.5M379%N/AN/A
Add Company

What Is Woodmark Pharmacy?

About Woodmark Pharmacy Established in 1993, Woodmark Pharmacy is a premier institutional pharmacy with corporate offices in New York, Massachusetts and Connecticut. Woodmark extends its coverage through these states to the entire northeastern U.S., including Rhode Island, New Hampshire, Maine and Connecticut. With a steadfast dedication to customer support, Woodmark prides itself on delivering custom pharmacy programs that integrate the latest technologies and detailed reporting so customers can make strategic business decisions with the help of our clinical, customer service and pharmaceutical teams.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$25.4M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.6M784%N/A
#2
$7.5M783%N/A
#3
$27.1M7822%N/A
#4
$75M7816%N/A
#5
$14.2M7922%N/A